12:00 AM
 | 
Jul 30, 2012
 |  BC Week In Review  |  Company News  |  Deals

Galapagos, Servier deal

Galapagos received an undisclosed million milestone payment from Servier under a 2010 deal to discover and develop small molecules against undisclosed targets for osteoarthritis (OA). The payment was triggered by selection of...

Read the full 138 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >